GENERATE BIOMEDICINES, INC.
GENBLoading price...
Profit/Loss
| PARTICULARS | TTM | 2025 | 2024 |
|---|---|---|---|
| Operating Revenue | 26.48M | 31.89M | 20.46M |
| Operating Expenses | 288.97M | 266.96M | 217.40M |
| Profit after Tax (Net Income) | -237.74M | -203.15M | -173.77M |
| PARTICULARS | TTM | 2025 | 2024 |
|---|---|---|---|
| Operating Revenue | 26.48M | 31.89M | 20.46M |
| Operating Expenses | 288.97M | 266.96M | 217.40M |
| Profit after Tax (Net Income) | -237.74M | -203.15M | -173.77M |